Helicobacter pylori Infection and Gastroesophageal Reflux Disease–Barrett’s Esophagus–Esophageal Adenocarcinoma Sequence

Kountouras J., Doulberis M., Polyzos S.A., Zeglinas C., Vardaka E., Kountouras C., Tzivras D., Dardiotis E., Exadaktylos A., Katsinelos P.

A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection

Kountouras J., Doulberis M., Papaefthymiou A., Polyzos S.A., Vardaka E., Tzivras D., Dardiotis E., Deretzi G., Giartza-Taxidou E., Grigoriadis S., Katsinelos P. (2019)

Gastroesophageal reflux disease (GERD) and the increasing rate of its associated complications, including esophageal adenocarcinoma (EAC), has stimulated a plethora of studies attempting to evaluate provocative and protective ...

Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease

Papaefthymiou A., Doulberis M., Polyzos S.A., Katsinelos P., Liatsos C., Koffas A., Kazakos E., Deretzi G., Srivastava D.S., Kountouras J. (2020)

[No abstract available]

Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis

Kountouras J., Boziki M., Polyzos S.A., Katsinelos P., Gavalas E., Zeglinas C., Tzivras D., Romiopoulos I., Giorgakis N., Anastasiadou K., Vardaka E., Kountouras C., Kazakos E., Xiromerisiou G., Dardiotis E., Deretzi G. (2017)

Helicobacter pylori (H. pylori) induces reactive oxygen species (ROS) production that contribute to pathogenesis of a variety of H. pylori-related gastric diseases, as shown in animal and human studies. Helicobacter pylori ...